2010 US Sales: $3.8 billion
Crestor is a cholesterol drug designed to help lower LDL (bad) cholesterol and raise HDL (good) cholesterol. It also slows the progressions of atherosclerosis, a condition that blocks arteries.
Crestor is one of the most profitable drugs in AstraZeneca’s portfolio.
The patent for Crestor expires in 2016, at which time generic competition will be fierce.